• Member Statistics

    • 776,934 Colleagues-to-Date [Sponsored by a generous R&D grant from iMBA, Inc.]
  • David E. Marcinko [Editor-in-Chief]

    As a former Dean and appointed Distinguished University Professor and Endowed Department Chair, Dr. David Edward Marcinko MBA was a NYSE broker and investment banker for a decade who was respected for his unique perspectives, balanced contrarian thinking and measured judgment to influence key decision makers in strategic education, health economics, finance, investing and public policy management.

    Dr. Marcinko is originally from Loyola University MD, Temple University in Philadelphia and the Milton S. Hershey Medical Center in PA; as well as Oglethorpe University and Emory University in Georgia, the Atlanta Hospital & Medical Center; Kellogg-Keller Graduate School of Business and Management in Chicago, and the Aachen City University Hospital, Koln-Germany. He became one of the most innovative global thought leaders in medical business entrepreneurship today by leveraging and adding value with strategies to grow revenues and EBITDA while reducing non-essential expenditures and improving dated operational in-efficiencies.

    Professor David Marcinko was a board certified surgical fellow, hospital medical staff President, public and population health advocate, and Chief Executive & Education Officer with more than 425 published papers; 5,150 op-ed pieces and over 135+ domestic / international presentations to his credit; including the top ten [10] biggest drug, DME and pharmaceutical companies and financial services firms in the nation. He is also a best-selling Amazon author with 30 published academic text books in four languages [National Institute of Health, Library of Congress and Library of Medicine].

    Dr. David E. Marcinko is past Editor-in-Chief of the prestigious “Journal of Health Care Finance”, and a former Certified Financial Planner® who was named “Health Economist of the Year” in 2010. He is a Federal and State court approved expert witness featured in hundreds of peer reviewed medical, business, economics trade journals and publications [AMA, ADA, APMA, AAOS, Physicians Practice, Investment Advisor, Physician’s Money Digest and MD News] etc.

    Later, Dr. Marcinko was a vital recruited BOD member of several innovative companies like Physicians Nexus, First Global Financial Advisors and the Physician Services Group Inc; as well as mentor and coach for Deloitte-Touche and other start-up firms in Silicon Valley, CA.

    As a state licensed life, P&C and health insurance agent; and dual SEC registered investment advisor and representative, Marcinko was Founding Dean of the fiduciary and niche focused CERTIFIED MEDICAL PLANNER® chartered professional designation education program; as well as Chief Editor of the three print format HEALTH DICTIONARY SERIES® and online Wiki Project.

    Dr. David E. Marcinko’s professional memberships included: ASHE, AHIMA, ACHE, ACME, ACPE, MGMA, FMMA, FPA and HIMSS. He was a MSFT Beta tester, Google Scholar, “H” Index favorite and one of LinkedIn’s “Top Cited Voices”.

    Marcinko is “ex-officio” and R&D Scholar-on-Sabbatical for iMBA, Inc. who was recently appointed to the MedBlob® [military encrypted medical data warehouse and health information exchange] Advisory Board.

    entrepreneur

    Frontal_lobe_animation

  • ME-P Information & Content Channels

  • ME-P Archives Silo [2006 – 2019]

  • Ann Miller RN MHA [Managing Editor]

    ME-P SYNDICATIONS:
    WSJ.com,
    CNN.com,
    Forbes.com,
    WashingtonPost.com,
    BusinessWeek.com,
    USNews.com, Reuters.com,
    TimeWarnerCable.com,
    e-How.com,
    News Alloy.com,
    and Congress.org

    Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners(TM)

    Product Details

    Product Details

    Product Details

  • CERTIFIED MEDICAL PLANNER® program

    New "Self-Directed" Study Option SinceJanuary 1st, 2018
  • Most Recent ME-Ps

  • PodiatryPrep.org


    BOARD CERTIFICATION EXAM STUDY GUIDES
    Lower Extremity Trauma
    [Click on Image to Enlarge]

  • ME-P Free Advertising Consultation

    The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]

    Product Details

    Product Details

  • Medical & Surgical e-Consent Forms

    ePodiatryConsentForms.com
  • iMBA R&D Services

    Commission a Subject Matter Expert Report [$250-$999]January 1st, 2019
    Medical Clinic Valuations * Endowment Fund Management * Health Capital Formation * Investment Policy Statement Analysis * Provider Contracting & Negotiations * Marketplace Competition * Revenue Cycle Enhancements; and more! HEALTHCARE FINANCIAL INDUSTRIAL COMPLEX
  • iMBA Inc., OFFICES

    Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.770.448.0769]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.

  • ME-P Publishing

  • SEEKING INDUSTRY INFO PARTNERS?

    If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].

  • Reader Comments, Quips, Opinions, News & Updates

  • Start-Up Advice for Businesses, DRs and Entrepreneurs

    ImageProxy “Providing Management, Financial and Business Solutions for Modernity”
  • Up-Trending ME-Ps

  • Capitalism and Free Enterprise Advocacy

    Whether you’re a mature CXO, physician or start-up entrepreneur in need of management, financial, HR or business planning information on free markets and competition, the "Medical Executive-Post” is the online place to meet for Capitalism 2.0 collaboration. Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds. ******************************************************************** THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
  • OIG Fraud Warnings

    Beware of health insurance marketplace scams OIG's Most Wanted Fugitives at oig.hhs.gov

Craig Venter Unveils Synthetic Life

Join Our Mailing List

Some Positive Video News on Memorial Weekend 2010

By Dr. David Edward Marcinko; MBA, CMP ™

Was Artificial Life Created Recently?

According to Craig Venter “synthetic life” has been created. Venter is the American biologist and entrepreneur most famous for his role in being one of the first to sequence the human genome. He has now reportedly synthesized the first artificial cell.

I don’t know about you, but this is huge news – regardless of whether you call it “life” or not.  In fact, here’s video of Craig Venter making the announcement:

An Arm Chair Philosopher

Now, I am not speaking as a doctor or scientist; but rather as an armchair economist and philosopher recalling my undergraduate days at Loyola University Maryland, under the tutelage of the late Aldo Tassi PhD. So, I repeat, this is huge news and an interesting piece of science. It is historic, and has large implications for the future and even the economy. Why?

The Invisible Hand

Much of our time here at the ME-P is spent integrating the hard and soft sciences of practice management, economics and financial planning for a medical audience. But occasionally, negative situations, political cycles and pessimistic opinions on our topic channels are expressed. These disparaging political remarks even indirectly target the USA and our very survival as a free nation and self-governing people.

IOW: Contrary to innovations, and innovators, like Craig Venter.

Nevertheless, there an “invisible hand” – call it economics or capitalism – that keeps us moving in the direction of survival. And, we are conscious beings capable of controlling the rate of that progression in all fields of human endeavor.

What it Is

A chromosome was designed in digital code on a computer and then transplanted into a bacterial cell, transforming that cell into a new bacterial species. Apart from the usual blueprint for proteins, the DNA also carried the names of the key contributors and even its own email address.

How it Works

As reported according to Venter, “This is the first self-replicating species on the planet, whose parent is a computer.”

And, he has already mentioned some potential practical applications for his discovery: a vaccine for HIV and a new strain of algae that can significantly decrease CO2-levels and provide a source for gasoline.

Link: http://www.jcvi.org

Assessment

And so, on this Memorial Weekend – a day for remembering death and sacrifice – let us celebrate life and achievement instead by stating that we are not apologists for the USA.

As the last best hope for this planet, we are not always right or politically correct, but this country offers the greatest opportunity on earth for human advancement, capitalism and success through conscientious work effort.

We do not believe America has seen better days. Those who fought did not die in vain. Better days are still in our future. We are optimistic about the long-term future of our country when looking at our progression to ameliorate the planet’s ills, to-date. We have come out of hard times before – like the current recession – by taking innovative steps forwards, not backwards. While we are likely to go through a period of adjustment in the near-term, the end result will be further individual, national and private progress in the USA. God Bless America.

Rest assured, we will continue to lead and create the world, much like Crag Venter created artificial life. Candor – Intelligence – Goodwill to all

Conclusion

And so, your thoughts and comments on this ME-P are appreciated. What do you think of this development? What economic discoveries, medical cures, life enhancing inventions and/or break-thru innovations will this creation open up?

Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, be sure to subscribe. It is fast, free and secure.

Channel Surfing the ME-P

Have you visited our other topic channels? Established to facilitate idea exchange and link our community together, the value of these topics is dependent upon your input. Please take a minute to visit. And, to prevent that annoying spam, we ask that you register. It is fast, free and secure.

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct Details

12 Responses

  1. Dr. Marcinko

    Craig Venter’s celebrity bacterium is expensive, glitzy and banal… but, as you know, it is not artificial life.

    http://www.zimvi.com/?p=4753

    But, I do appreciate the larger issue of the American spirit and innovative way of life on this Memorial Day and weekend.

    Gregory

    Like

  2. Cures … not so Fast!

    Ten years after mapping the human genome, there are few cures.

    http://www.msnbc.msn.com/id/37663949/ns/health-the_new_york_times

    This is a great achievement and insights are plentiful, but treatments for common diseases are still elusive.

    Dr. Gene

    Like

  3. On Artificial Intelligence

    Stephen Hawking is right?

    http://www.msn.com/en-us/news/technology/stephen-hawking-is-right%e2%80%94the-ai-arms-race-is-already-here/ar-AAdFRxT?ocid=iehp

    The AI arms race is already here!

    Bruster

    Like

  4. Internet of Things, artificial intelligence, machine learning: Closer than we think?

    An expert from the Advisory Board says clinicians and physicians should be far more prepared than they are today for the onslaught of technologies that once seemed space age.

    http://www.healthcareitnews.com/news/himss-speaker-internet-things-gives-rise-smart-machines-deep-learning-healthcare

    Ann Miller RN MHA

    Like

  5. Ethical Questions Loom Over Efforts to Make a Human Genome from Scratch

    The biggest beneficiary of a plan to fabricate a human genome from scratch could be a Massachusetts startup called Gen9 that has close ties to the authors of the still-secretive proposal.

    Read more:https://www.technologyreview.com/s/601540/ethical-questions-loom-over-efforts-to-make-a-human-genome-from-scratch/?ct=t(Newsletter_2014_07_177_17_2014)

    Hope Hetico RN MHA

    Like

  6. A DNA teleporter could send life into space

    We can sequence genomes. We can store them digitally. We can send that information through space. And we can use it to build synthetic DNA. See where this is going?

    In the labs of Synthetic Genomics, originally founded by Craig Venter, those processes have been combined to create a device that uses transmitted digital code to print viruses.

    https://www.technologyreview.com/s/608388/biological-teleporter-could-speed-outbreak-response-seed-life-through-galaxy/?utm_source=MIT+Technology+Review&utm_campaign=453245b713-The_Download&utm_medium=email&utm_term=0_997ed6f472-453245b713-154253973

    Alonzo

    Like

  7. Synthetic life uses unnatural DNA to make new proteins

    Every living thing on Earth stores instructions for life as DNA, using the four genetic bases: A, G, C, and T. All except one, that is.

    In a San Diego lab, researchers have grown E. Coli bacteria with two more letters, an “unnatural” pair called X and Y. And now, for the first time, the germs are using the expanded code to make proteins with equally unusual components.

    We explain how it works, and why it’s a big deal.
    https://www.technologyreview.com/s/609567/semi-synthetic-life-form-now-fully-armed-and-operational/?utm_source=newsletters&utm_medium=email&utm_content=11-30-2017&utm_campaign=the_download&utm_source=MIT+Technology+Review&utm_campaign=863d23532c-The_Download&utm_medium=email&utm_term=0_997ed6f472-863d23532c-154253973

    Alfonzo

    Like

  8. Is Crispr Therapeutics Stock Grossly Overvalued?

    Crispr’s stock has started to lose momentum after blasting higher earlier this year. Is the market correcting a prior mistake, or is this dip a buying opportunity?

    https://www.fool.com/investing/2018/08/09/is-crispr-therapeutics-stock-grossly-overvalued.aspx

    Mike

    Like

  9. CRISPR

    Chinese Gene Editing Scientist May Face Death Penalty;

    http://www.msn.com/en-us/news/world/chinese-gene-editing-scientist-may-face-death-penalty/ar-BBRXHI6?li=BBnbfcL

    Dr. David E. Marcinko MBA

    Like

  10. Congress is about to renew its ban on creating CRISPR babies in the US

    In an effort to unblock US government funding, the House of Representatives will vote on a bill that would renew the prohibition on genetically modified humans in the US.

    Baby ban: Since 2015, the US has adopted language in funding bills that prohibits the Food and Drug Administration from considering any application to create IVF children from embryos that have been geneticallymodified. But it has to be renewed every year.

    What’s prohibited: The ban covers gene-edited babies like those allegedly born recently in China. The FDA commissioner, Scott Gottlieb, is deeply opposed to softening the CRISPR baby rule. It also blocks a technique that creates what has been dubbed “three-parentbabies.”

    However: By blanket banning all DNA changes to an embryo, Congress is missing a chance “to craft a better, more subtle policy” that could allow real public debate on new reproductive technologies, saysGlenn Cohen, a professor at Harvard Law School.

    Dr. David E. Marcinko MBA
    [MIT Technology Review]

    Like

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: